infectious disease

News

FDA advisors back Beyfortus for RSV prevention

An FDA advisory committee has voted in favour of approving AstraZeneca and Sanofi’s one-shot antibody treatment to prevent respiratory syncytial virus (RSV) disease in inf

News

SNIPR shoots down resistant E. coli in first human trial

SNIPR Biome has said its CRISPR therapeutic targeting a problem bacterial pathogen has shown proof-of-concept in a phase 1 trial, raising hopes of a new way to treat resis

News

AI-based infectious disease detector gets UK funding

The UK government has agreed to support the development of a rapid diagnostic from Oxford medtech firm Pictura Bio that could help manage infectious diseases amongst milit

News

Innoviva gets FDA nod for pneumonia antibiotic

The FDA has given a green light to Innoviva’s antibiotic combination Xacduro, which becomes the first drug specifically approved for pneumonia caused by hard-to-treat bact

News

GSK chases down Pfizer in 5-in-1 meningitis jab contest

Armed with new data, GSK is preparing to file for approval of its new-generation meningitis vaccine, as it tries to maintain its leadership in the category against a chall

News

WHO declares end of COVID-19 emergency

The World Health Organization (WHO) has said that COVID-19 is no longer a public health emergency of international concern (PHEIC), more than three years after it first de

FDA advisors back Beyfortus for RSV prevention

SNIPR shoots down resistant E. coli in first human trial

AI-based infectious disease detector gets UK funding

Innoviva gets FDA nod for pneumonia antibiotic

GSK chases down Pfizer in 5-in-1 meningitis jab contest

WHO declares end of COVID-19 emergency

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

infectious disease

Editor's Picks